AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18060588
Drug: PB supplement
RxNorm normalized name: PB-722
DrugBank: PB-722 (DB18447)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PB supplement (0.545 g PB dissolved in 750 mL apple juice)
Trial: 18060588
Drug: 750 mL
RxNorm normalized name: ALCOHOL 750 mL in 1 L TOPICAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mL apple juice (control)
Trial: 14984384
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid plus paracetamol plus caffeine
Trial: 3237227
Drug: 20 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/kg phenobarbital
Trial: 3237227
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg phenobarbital
Trial: 30450925
Drug: β‐blocker uptitration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β‐blocker uptitration
Trial: 26900091
Drug: Concurrent chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiotherapy with cetuximab (Arm B)
Trial: 26900091
Drug: Concurrent chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiotherapy without cetuximab (Arm A)
Trial: 16758263
Drug: Itraconazole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (100 mg, first dose 200 mg)
Trial: 20150523
Drug: Gemfibrozil (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil (600 mg)
Trial: 16758263
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of itraconazole and gemfibrozil
Trial: 12890944
Drug: Postnatal steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postnatal steroid therapy
Trial: 12890944
Drug: Guidelines for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guidelines for steroid use by the American Academy of Pediatrics and the Canadian Paediatric Society
Trial: 29177955
Drug: Creatine monohydrate
RxNorm normalized name: Creatine Monohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine monohydrate 6 g daily (N = 17)
Trial: 27053380
Drug: Maternal LCPUFA
RxNorm normalized name: undecylenate
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maternal LCPUFA supplementation (1020 mg DHA plus 180 mg EPA/d)
Trial: 20223994
Drug: Exercise plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise plus volume infusion (dextran)
Trial: 20223994
Drug: Volume infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Volume infusion alone (dextran)
Trial: 11952026
Drug: IM ertapenem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM ertapenem 1 g once daily
Trial: 11952026
Drug: IM ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM ceftriaxone 1 g once daily
Trial: 10075344
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g raw flaxseed
Trial: 10075344
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g raw flaxseed
Trial: 10075344
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g raw flaxseed
Trial: 10075344
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g processed flaxseed (muffin or bread)
Trial: 10075344
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g flaxseed (raw or processed)
Trial: 2027481
Drug: Low-dose prednisone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prednisone (0.75 mg/kg/d)
Trial: 2027481
Drug: High-dose prednisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose prednisone (1.5 mg/kg/d)
Trial: 30651222
Drug: SIT-STAND (sitting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIT-STAND (sitting with hourly 10-min standing interruptions)
Trial: 25212541
Drug: Pharmacist counselling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist counselling before starting chemotherapy
Trial: 25212541
Drug: Follow-up with
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Follow-up with the pharmacist after starting chemotherapy
Trial: 17114889
Drug: Sublingual-swallow immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual-swallow immunotherapy (SLIT) with Juniperus ashei allergen extract
Trial: 16394701
Drug: 550 mg
RxNorm normalized name: xylitol 550 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 550 mg naproxen
Trial: 15383182
Drug: Captodiamine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captodiamine (150 mg/d)
Trial: 10735891
Drug: Suramin plus
RxNorm normalized name: suramin
DrugBank: Suramin (DB04786)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suramin plus hydrocortisone (HC, 40 mg/d)
Trial: 8923333
Drug: 12.5 mg
RxNorm normalized name: rutin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg of doxylamine succinate administered orally every 6 h for 17 days
Trial: 8923333
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of phenobarbital administered orally every 6 h for 17 days
Trial: 8923333
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered orally every 6 h for 17 days
Trial: 4053337
Drug: Slow inspiratory
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow inspiratory flow rates (15-30 l/min)
Trial: 4053337
Drug: Flow rates
RxNorm normalized name: Quarter Mate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flow rates higher than 70 l/min
Trial: 26250523
Drug: Thymosin α1
RxNorm normalized name: chymosin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymosin α1 (Tα1) plus routine treatment
Trial: 24081937
Drug: Sunitinib 37.5
RxNorm normalized name: sunitinib 37.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunitinib 37.5 mg once per day
Trial: 24297950
Drug: Sorafenib 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib 400 mg twice per day
Trial: 21694621
Drug: Antidepressant use
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant use (citalopram, sertraline, paroxetine)
Trial: 21694621
Drug: No antidepressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antidepressant use
Trial: 12597703
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg MPH
Trial: 12597703
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg MPH
Trial: 18582178
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg MPH
Trial: 16538239
Drug: Olibra fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olibra fat emulsion (5 g of Olibra fat)
Trial: 16538239
Drug: Control (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (5 g milk fat)
Trial: 8836933
Drug: Sustained-release (SR)
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release (SR) levodopa preparation (100 mg and 200 mg)
Trial: 8836933
Drug: Conventional immediate-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional immediate-release (IR) levodopa preparation (100 mg)
Trial: 8836933
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of SR and IR levodopa (70% SR and 30% IR)
Trial: 1417666
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E administration at a dose of 100 mg daily for three weeks
Trial: 1417666
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A administration
Trial: 23756453
Drug: Goal-Directed Therapy
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-Directed Therapy (GDT)
Trial: 24474602
Drug: TAU+P (treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAU+P (treatment as usual combined with clinician-lead cognitive behavioural treatment for perfectionism)
Trial: 21965526
Drug: Aliskiren (direct
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren (direct renin inhibitor), n=423
Trial: 27936941
Drug: Aliskiren (direct
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren (direct renin inhibitor)
Trial: 11765586
Drug: Metformin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (2 × 850 mg/day)
Trial: 11765586
Drug: Acarbose (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (3 × 100 mg/day)
Trial: 12475829
Drug: Enoxaparin, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin, 40 mg/d
Trial: 12475829
Drug: Heparin, 5,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin, 5,000 U bid
Trial: 6957982
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg PIR twice daily
Trial: 31207152
Drug: Live Zoster
RxNorm normalized name: Varicella zoster vaccine (live/attenuated)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live Zoster Vaccine (LZV)
Trial: 31207152
Drug: Tofacitinib 5
RxNorm normalized name: tofacitinib 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 5 mg BID plus MTX
Trial: 31207152
Drug: Adalimumab (ADA)
RxNorm normalized name: Adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adalimumab (ADA) 40 mg every other week plus MTX
Trial: 19140095
Drug: 360 mg
RxNorm normalized name: aspirin 360 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 360 mg verapamil daily for 6 days
Trial: 10750752
Drug: hANP (human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hANP (human atrial natriuretic peptide) administered for 24 hours from the start of CPB
Trial: 4025853
Drug: Etomidate (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate (0.4 mg/kg)
Trial: 1529939
Drug: Fruits and
RxNorm normalized name: Aminobenzoic Acid/Ascorbic Acid/Biotin/Calcium/Cholecalciferol/Choline Bitartrate/Copper/Cyanocobalamin/Folic Acid/Inositol/Iodine/Iron/Magnesium/Manganese/Niacin/Pantothenic Acid/Phosphorus/Pyridoxine/Riboflavin/Thiamine/Vitamin A/Vitamin E/Zinc 5 MG-180 MG-300 MCG-120 MG-30 MCG-5 MG-2 MG-18 MCG-800 MCG-5 MG-150 MCG-18 MG-100 MG-2 MG-20 MG-30 MG-15 MG-2 MG-5.1 MG-4.5 MG-2250 MCG-7 MG-5 MG Oral Tablet [MEGAVITE WITH FRUITS AND VEGGIES]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fruits and vegetables (administered for 12 weeks)
Trial: 4074606
Drug: Felodipine 10
RxNorm normalized name: felodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 10 mg oral solution
Trial: 3304706
Drug: Timolol (5.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol (5.5 mg iv as a bolus divided into four doses during the first 2 hours followed by 10 mg orally twice daily for 1 month)
Trial: 28288611
Drug: Resistance exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistance exercise (twice weekly for 15 weeks)
Trial: 25774705
Drug: Low-glycaemic-index (LGI)
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-glycaemic-index (LGI) diet and Policaptil Gel Retard
Trial: 20534951
Drug: Oral itraconazole
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral itraconazole solution mixed with orange juice
Trial: 20534951
Drug: Oral itraconazole
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral itraconazole solution with water
Trial: 18503623
Drug: Levobupivacaine 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine 3 mg/mL
Trial: 18503623
Drug: Ropivacaine 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 4.5 mg/mL
Trial: 18503623
Drug: Bupivacaine 3
RxNorm normalized name: BUPivacaine 300 MG / meloxicam 9 MG in 10.5 ML Extended Release Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 3 mg/mL
Trial: 9089669
Drug: Clonidine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (1.5 micrograms kg‐1 in 10 ml infused intravenously over 10 min) at 20 degrees C
Trial: 9089669
Drug: Clonidine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (1.5 micrograms kg‐1 in 10 ml infused intravenously over 10 min) at 40 degrees C
Trial: 4013628
Drug: Centrally acting
RxNorm normalized name: Other centrally acting agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Centrally acting analgesics alone
Trial: 30185931
Drug: Thyroid hormone
RxNorm normalized name: Thyroid hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroid hormone replacement treatment
Trial: 19022123
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) administered into extraction sockets
Trial: 16798622
Drug: subcutaneous recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: subcutaneous recombinant interleukin-2 (rIL-2) plus antiretroviral therapy (ART)
Trial: 14714359
Drug: Jiexiao Oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jiexiao Oral Liquid (JXOL)
Trial: 14714359
Drug: Virazole (10-15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virazole (10-15 mg.kg-1.d-1)
Trial: 9363044
Drug: Abecarnil (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abecarnil (high dosage)
Trial: 9363044
Drug: Abecarnil (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abecarnil (low dosage)
Trial: 1526085
Drug: Bendroflumethiazide (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendroflumethiazide (5 mg daily for 1 week)
Trial: 1526085
Drug: Transbuccal nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transbuccal nitroglycerin (0.25 mg)
Trial: 29776960
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (2.5 mg), vitamin B6 (50 mg), vitamin B12 (1 mg)
Trial: 18950439
Drug: 4% lidocaine
RxNorm normalized name: Lidocaine 344 mg TOPICAL PATCH [Pain Relief 4% Lidocaine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% lidocaine (active) injections
Trial: 18950439
Drug: saline (control)
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: saline (control) injections
Trial: 12598775
Drug: Nevirapine 200
RxNorm normalized name: nevirapine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nevirapine 200 mg once weekly (cohort A, n = 12)
Trial: 12598775
Drug: Nevirapine 200
RxNorm normalized name: nevirapine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nevirapine 200 mg twice weekly (cohort B, n = 12)
Trial: 12598775
Drug: Nevirapine 200
RxNorm normalized name: nevirapine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nevirapine 200 mg every other day (cohort C, n = 9)
Trial: 8604065
Drug: Conventional buccal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional buccal approach
Trial: 1782718
Drug: Diclofenac 50
RxNorm normalized name: DICLOFENAC 50MG/MISOPROSTOL 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 50 mg preoperatively and 50 mg post-operatively
Trial: 1782718
Drug: Diclofenac 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 100 mg post-operatively only
Trial: 6451354
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment (urea vehicle)
Trial: 31751935
Drug: Ketone salt
RxNorm normalized name: Ketonal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketone salt (KS) supplement (0.38 g/kg body mass)
Trial: 25163489
Drug: Dexamethasone 12
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone 12 mg intramuscularly, two doses 24 hours apart
Trial: 25163489
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care without steroids
Trial: 24008568
Drug: 1 µg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 µg/kg remifentanil
Trial: 24008568
Drug: 2 µg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 µg/kg remifentanil
Trial: 7581113
Drug: Cytokine-mediated immunotherapy
RxNorm normalized name: cytosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokine-mediated immunotherapy
Trial: 2198301
Drug: Buspirone 5-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone 5-30 mg/day
Trial: 25545376
Drug: Ferric maltol
RxNorm normalized name: Ferric Maltol
DrugBank: Ferric maltol (DB15598)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ferric maltol (30 mg twice a day)
Trial: 25202177
Drug: Kinesio Taping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kinesio Taping (KT) combined with conventional physical therapy (n=20)
Trial: 25202177
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy only (n=20)
Trial: 11752036
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (4000 mg)
Trial: 11752036
Drug: Control oil
RxNorm normalized name: SALICYLIC ACID 29.2 mg TOPICAL LIQUID [Acne Control oil-free Cleansing]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control oil (4000 mg)
Trial: 9056732
Drug: Traditional diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional diet and yogurt combination
Trial: 7686187
Drug: 0.025% tretinoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.025% tretinoin cream applied once daily for 9 months
Trial: 7686187
Drug: Vehicle cream
RxNorm normalized name: vehicle cream base no.160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle cream applied once daily for 9 months
Trial: 3523043
Drug: Adjuvant chemo-immunotherapy
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemo-immunotherapy (BCG or BCG plus tumor cell vaccine)
Trial: 27272818
Drug: Combined active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined active groups (single-dose, repeated-dose, continuous infusion)
Trial: 17610993
Drug: Imiquimod 5%
RxNorm normalized name: Imiquimod 5% Topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 5% cream applied thrice weekly for 8 weeks
Trial: 17610993
Drug: Imiquimod 5%
RxNorm normalized name: Imiquimod 5% Topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 5% cream applied thrice weekly for 12 weeks
Trial: 17610993
Drug: Imiquimod 5%
RxNorm normalized name: Imiquimod 5% Topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 5% cream applied thrice weekly for both durations
Trial: 17610993
Drug: Imiquimod 5%
RxNorm normalized name: Imiquimod 5% Topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 5% cream applied thrice weekly
Trial: 16083538
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate (MF) dry powder inhaler (DPI) 400 microg qd PM (one inhalation)
Trial: 11935106
Drug: Computed tomographic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computed tomographic discography using intradiscal iodinated contrast agent
Trial: 25528574
Drug: Erythropoietin 40,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin 40,000 IU administered weekly for up to three doses
Trial: 25528574
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered weekly for up to three doses
Trial: 9437195
Drug: Alpha-tocopherol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-tocopherol (50 mg daily)
Trial: 9437195
Drug: Beta-carotene (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene (20 mg daily)
Trial: 2511693
Drug: 0.025 mg
RxNorm normalized name: lisuride 0.025 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.025 mg nitroglycerin intravenously
Trial: 4544476
Drug: Polarizing solution:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polarizing solution: continuous intravenous perfusion during 7 days of one liter daily of a 10% glucose solution with potassium (40 m Eq/L) and insulin (20 units)
Trial: 4544476
Drug: Control group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group: slow perfusion (one liter daily) of a 5% glucose solution
Trial: 26279580
Drug: Caffeinated energy
RxNorm normalized name: Senergy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated energy drink (3 mg/kg)
Trial: 26693858
Drug: Placebo (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0 mg/kg)
Trial: 20962338
Drug: High-dose tirofiban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose tirofiban (HDT) pretreatment
Trial: 20962338
Drug: Bail-out use
RxNorm normalized name: Cough Out
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bail-out use of study medication
Trial: 18328334
Drug: Treatment (specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment (specific pharmacologic treatment not detailed)
Trial: 18328334
Drug: On treatment
RxNorm normalized name: STIX 3 DAY YEAST INFECTION TREATMENT KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On treatment (no specific intervention mentioned)